Related Experiment Videos
Aging and determinants of hepatic drug clearance
1Clinical Pharmacology and Gerontology Research Unit, Veterans Administration Medical Center, Boise, Idaho 83702.
Hepatology (Baltimore, Md.)
|February 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of cyclopentyladenosine on isoproterenol response in adult and senescent cardiac tissue from Fischer 344 rats.
The Journal of pharmacology and experimental therapeutics·2000
Cloning and characterization of human oncostatin M promoter.
Nucleic acids research·1999
Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide.
The Journal of pharmacology and experimental therapeutics·1999
Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
The Journal of pharmacology and experimental therapeutics·1999
Inhibition of human cytochrome P450 1A2 by flavones: a molecular modeling study.
Journal of protein chemistry·1998
Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.
Hepatology (Baltimore, Md.)·2026
Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.
Hepatology (Baltimore, Md.)·2026
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
Hepatology (Baltimore, Md.)·2026
Social determinants of abdominal tuberculosis severity: An experience from a large tertiary care center.
Pakistan journal of medical sciences·2026
Epidemiological pattern of tuberculosis in Babol City, northern Iran (2015-2021).
Caspian journal of internal medicine·2026
Diabetes burden and health expenditure in Türkiye and OECD countries: A value-based health care perspective.
Pakistan journal of medical sciences·2026